Techh.info/biomedtechnology hourly

Cancer

headlines texts
21.03.2019
09:20 News-Medical.NetNew computer program developed by TGen lights up cancer-causing genetic mutations

By conjuring the spell "Lumos!" wizards in the mythical world of Harry Potter could light up the tip of their magic wands and illuminate their surroundings. So, too, does LumosVar, a computer program developed by the Translational Genomics Research Institute, "light up" cancer-causing genetic Var-ients, or mutations, illuminating how physicians might best treat their patients.

Скрыть анонс
07:50 News-Medical.NetResearchers discover possible new therapeutic strategy for pancreatic cancer

Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a possible new therapeutic strategy using two types of drug inhibitors at once to treat one of the world's deadliest cancers.

Скрыть анонс
05:45 ScienceDaily.comPotential new combination treatment for pancreatic cancer

Researchers have identified a possible new therapeutic strategy using two types of drug inhibitors at once to treat one of the world's deadliest cancers.

Скрыть анонс
04:34 Yahoo.com BusinessDrink hot tea at your own risk: New study is latest to show link to esophageal cancer

http://news.yahoo.com/rss/businesshttp://news.yahoo.com/rss/businesshttp://news.yahoo.com/rss/businesshttp://news.yahoo.com/rss/businesshttp://news.yahoo.com/rss/businessNhttp://news.yahoo.com/rss/businessehttp://news.yahoo.com/rss/businesswhttp://news.yahoo.com/rss/business http://news.yahoo.com/rss/businessrhttp://news.yahoo.com/rss/businessehttp://news.yahoo.com/rss/businessshttp://news.yahoo.com/rss/businessehttp://news.yahoo.com/rss/businessahttp://news.yahoo.com/rss/businessrhttp://news.yahoo.com/rss/businesschttp://news.yahoo.com/rss/businesshhttp://news.yahoo.com/rss/business

Скрыть анонс
03:49 Yahoo ScienceThis Daily Habit Could Reduce Your Risk of Cancer by 20 Percent

You probably already do it, too!

Скрыть анонс
03:49 Yahoo ScienceSecond US jury finds Roundup weed killer caused cancer

A federal jury in California found that a Monsanto's Roundup weed killer caused a 70-year old man's cancer, the second major blow for the company in a year. The six-member jury in San Francisco federal civil court unanimously concluded on Tuesday that glyphosate — Roundup's key ingredient — was a "substantial factor" in Sonoma resident Edwin Hardeman’s non-Hodgkin’s lymphoma. Approximately 11,200 plaintiffs, who claim they were exposed to glyphosate, are suing the company as of Jan. 28, according to the company's annual report filed with the Securities and Exchange Commission (SEC).

Скрыть анонс
02:30 Nanowerk.comVisualizing better cancer treatment with nanoscale protein micelles

Researchers have engineered nanoscale protein micelles capable of both delivering chemotherapeutic drugs and of being tracked by magnetic resonance imaging (MRI).

Скрыть анонс
01:36 Yahoo ScienceSarah Silverman's 'butt' T-shirt garners interesting reactions — but nothing tops cancer survivor Marcia Cross's response

With just a few words, "Desperate Housewives" alum — a cancer survivor — turned the whole topic into an educational one.

Скрыть анонс
00:33 ScienceDaily.comProtein linked to cancer growth drives deadly lung disease

A protein associated with cancer growth appears to drive the deadly lung disease known as idiopathic pulmonary fibrosis, according to new research. The discovery, made in laboratory mice and human tissue samples, may have implications for treating the disease using existing anti-cancer therapies that inhibit the protein PD-L1.

Скрыть анонс
00:04 News-Medical.NetOverall rates of death from breast cancer are falling across the EU

Researchers at the University of Milan have predicted that death rates from breast cancer will fall this year in all European Union (EU) countries, with the exception of Poland.

Скрыть анонс
20.03.2019
23:59 ScienceDaily.comAs if by magic: Program lights up cancer-causing mutations

By conjuring the spell 'Lumos!' wizards in the mythical world of Harry Potter could light up the tip of their magic wands and illuminate their surroundings. So, too, does LumosVar, a computer program 'light up' cancer-causing genetic Var-ients, or mutations, illuminating how physicians might best treat their patients.

Скрыть анонс
23:55 Yahoo ScienceJury Finds Bayer's Weed Killer Caused A California Man's Cancer

A federal jury found Tuesday that the herbicide Roundup caused a man's non-Hodgkin's lymphoma.

Скрыть анонс
23:55 Washingtonpost.comBayer stock plummets after jury finds Roundup weedkillers caused man’s cancer

Bayer stock plunged more than 10 percent Wednesday and the company faces more lawsuits tied to allegations of cancer-causing chemicals.

Скрыть анонс
23:42 Technology.orgStudy: Free fatty acids appear to rewire cells to promote obesity-related breast cancer

Scientists at the University of Illinois have found that free fatty acids in the blood appear to boost

Скрыть анонс
23:42 Technology.orgMutations in noncoding genes could play big role in regulating cancer, study finds

RNA transcribed from genes that seem not to code for anything may play an important role in regulating

Скрыть анонс
22:49 Benzinga.comBayer's Legal Woes Mount As Jury Again Links Roundup To Cancer

German chemicals company Bayer AG (OTC: BAYRY) faced another legal setback this week as a federal court in San Francisco ruled in the first phase of a trial that its Roundup herbicide was a &quo
read more

Скрыть анонс
21:29 Yahoo ScienceU.S. jury hears more evidence as second phase of Roundup cancer trial begins

A lawyer for a man who sued Bayer AG unit Monsanto after developing cancer on Wednesday told a jury about the company's alleged efforts to influence scientists and regulators, a day after the jury found Bayer's glyphosate-based weed killer Roundup to have caused the man's disease. The jury in San Francisco federal court on Tuesday found Roundup to be a "substantial factor" in causing California resident Edwin Hardeman's non-Hodgkin's lymphoma, but did not find Bayer liable.

Скрыть анонс
21:29 Yahoo.com BusinessU.S. jury hears more evidence as second phase of Roundup cancer trial begins

A lawyer for a man who sued Bayer AG unit Monsanto after developing cancer on Wednesday told a jury about the company's alleged efforts to influence scientists and regulators, a day after the jury found Bayer's glyphosate-based weed killer Roundup to have caused the man's disease. The jury in San Francisco federal court on Tuesday found Roundup to be a "substantial factor" in causing California resident Edwin Hardeman's non-Hodgkin's lymphoma, but did not find Bayer liable.

Скрыть анонс
21:27 Reuters.com HealthU.S. jury hears more evidence as second phase of Roundup cancer trial begins

A lawyer for a man who sued Bayer AG unit Monsanto after developing cancer on Wednesday told a jury about the company's alleged efforts to influence scientists and regulators, a day after the jury found Bayer's glyphosate-based weed killer Roundup to have caused the man's disease.

Скрыть анонс
21:24 ReutersU.S. jury hears more evidence as second phase of Roundup cancer trial begins

A lawyer for a man who sued Bayer AG unit Monsanto after developing cancer on Wednesday told a jury about the company's alleged efforts to influence scientists and regulators, a day after the jury found Bayer's glyphosate-based weed killer Roundup to have caused the man's disease.

Скрыть анонс
21:22 Nature.ComNeoantigen-directed immune escape in lung cancer evolution

Скрыть анонс
21:22 ScienceDaily.comVisualizing better cancer treatment

Researchers have engineered nanoscale protein micelles capable of both delivering chemotherapeutic drugs and of being tracked by MRI. The innovation allows researchers to administer therapy while noninvasively monitoring the therapeutic progress and drastically reducing the need for surgical intervention. They biosynthesized a protein block copolymer containing amino acid building blocks with fluorinated thermoresponsive assembled protein (F-TRAP), which assembles into a nanoscale micelle with the noteworthy abilities.

Скрыть анонс
21:17 Yahoo ScienceStudy links drinking hot tea with elevated esophageal cancer risk

The research hails from the Tehran University of Medical Sciences in Iran and is published in The International Journal of Cancer. Scientists followed 50,045 individuals between the ages of 40 and 75 from 2004 to 2017. During this period, 317 new cases of esophageal cancer were identified. Drinking 700ml of tea per day at a temperature greater than or equal to 60°C was associated with a 90% higher risk of esophageal cancer.

Скрыть анонс
20:58 ScienceDaily.comBalance of two enzymes linked to pancreatic cancer survival

New research sets the stage for clinicians to potentially one day use levels of a pancreatic cancer patient's PHLPP1 and PKC enzymes as a prognostic, and for researchers to develop new therapeutic drugs that inhibit PHLPP1 and boost PKC as a means to treat the disease.

Скрыть анонс
19:45 Yahoo ScienceThe Psychology Behind People Who Fake Cancer

"That was a spectacularly rare case," said Marc Feldman, a psychiatrist whospecializes in factitious disorders and the author of Dying to Be Ill

Скрыть анонс
19:22 Yahoo SciencePfizer/Merck KGaA End Bavencio+Talzenna Ovarian Cancer Study

Pfizer (PFE) and Merck KGaA terminate a late-stage study on Bavencio and its new PARP inhibitor, Talzenna. This is the third ovarian cancer study failure in less than six months.

Скрыть анонс
19:22 Yahoo.com BusinessPfizer/Merck KGaA End Bavencio+Talzenna Ovarian Cancer Study

Pfizer (PFE) and Merck KGaA terminate a late-stage study on Bavencio and its new PARP inhibitor, Talzenna. This is the third ovarian cancer study failure in less than six months.

Скрыть анонс
18:35 Yahoo ScienceGlaxo Presents Encouraging Data on Endometrial Cancer Drug

Glaxo (GSK) presents encouraging data from phase I/II study on endometrial cancer drug, dostarlimab.

Скрыть анонс
18:35 Yahoo ScienceHancock accused of astonishing ignorance after he speaks about his prostate cancer risk

Matt Hancock has been accused of “an astonishing level of ignorance” after revealing that tests had found he is at increased risk of prostate cancer.   One leading geneticist said the Health Secretary had “massively misinterpreted” his results, and would be wasting NHS resources by booking an appointment to discuss the matter with his GP.   Mr Hancock revealed the results of his genetic tests as he called for the health service to roll out gene tests more widely. But scientists today criticised the drive, with Mr Hancock accused of making “frankly ridiculous” claims, in his speech to The Royal Society. Meanwhile GPs said encouraging people to routinely be tested for common diseases would uncover too many “unimportant” findings which would leave patients needlessly distressed, while heaping pressure on

Скрыть анонс
18:35 Yahoo.com BusinessGlaxo Presents Encouraging Data on Endometrial Cancer Drug

Glaxo (GSK) presents encouraging data from phase I/II study on endometrial cancer drug, dostarlimab.

Скрыть анонс
18:30 Financial TimesGoFundMe blocks appeals for controversial cancer clinic

Crowdfunders face scrutiny over unproven medical treatments

Скрыть анонс
18:27 ScienceDaily.comDrinking hot tea linked with elevated risk of esophageal cancer

Previous studies have revealed a link between hot tea drinking and risk of esophageal cancer, but until now, no study has examined this association using prospectively and objectively measured tea drinking temperature. A new study achieved this by following 50,045 individuals aged 40 to 75 years for a median of 10 years.

Скрыть анонс
18:07 News-Medical.NetBreast cancer relapse predictor tool may soon be a reality

Researchers have developed a tool by which they can predict accurately the time when breast cancer is likely to return.

Скрыть анонс
18:07 News-Medical.NetWorryingly long wait for NHS cancer patients

Around a fourth of NHS cancer patients have to wait a worryingly long amount of time to start treatment, according to a new NHS England report.

Скрыть анонс
18:04 ScienceDaily.comActive substance from plant slows down aggressive eye cancer

An active substance that has been known for 30 years could unexpectedly turn into a ray of hope against eye tumors. This is shown by a new study. The plant leaves of which contain the tested substance is anything but rare: At Christmas time you can find it in every well-assorted garden center.

Скрыть анонс
17:57 FT.com TechnologyGoFundMe blocks appeals for controversial cancer clinic

Crowdfunders face scrutiny over unproven medical treatments

Скрыть анонс
17:57 FT.com HealthGoFundMe blocks appeals for controversial cancer clinic

Crowdfunders face scrutiny over unproven medical treatments

Скрыть анонс
17:22 CancerNetwork.comSGO 2019: Dendritic Cell–Based Immunotherapy Shows “Dramatic” Response for Ovarian Cancer

The phase II trial evaluated dendritic cell–based immunotherapy with concomitant administration of chemotherapy vs chemotherapy alone.

Скрыть анонс
16:06 CNN HealthDrinking very hot tea almost doubles risk of cancer, new study says

Many people start their day with a cup of tea. But those who drink it piping hot could be increasing their risk of esophageal cancer, according to a new study.

Скрыть анонс
15:32 Technology.orgUW team finds key to common cancer pathway in discovery that could unlock new therapies

Scientists have long known that the protein p53, when mutated, is a critical factor in the onset of

Скрыть анонс
15:10 FinancialExpress.comThe disease Manohar Parrikar fought: Understanding what is Pancreatic Cancer

The detection of pancreatic cancers is also not easy as there are no specific screening tests and by the time symptoms sets in, it is mostly late though some are lucky to catch it early.

Скрыть анонс
15:05 ReutersBayer shares slide after latest Roundup cancer ruling

Shares in Germany's Bayer's fell more than 12 percent on Wednesday after a second U.S. jury ruled its Roundup weed killer caused cancer.

Скрыть анонс
14:44 Reuters.com HealthBayer shares slide after latest Roundup cancer ruling

Shares in Germany's Bayer's fell more than 12 percent on Wednesday after a second U.S. jury ruled its Roundup weed killer caused cancer.

Скрыть анонс
14:34 Yahoo ScienceGirl gives bald American Girl dolls to young cancer patients

An 11-year-old is spreading smiles by delivering bald American Girl dolls to kids fighting cancer. With help from her mom, Bella Fricker, 11, of Alpharetta, Georgia, raises money to buy the dolls and delivers them to hospitalized patients. Fricker, a mom of three, said Bella launched the Peace Love Bracelets Foundation over a year ago.

Скрыть анонс
14:21 FinancialExpress.comPiping hot tea, coffee may up oesophageal cancer risk: Study

Compared with drinking less than 700 ml of tea per day at less than 60 degrees Celsisu, drinking 700 ml per day or more at a higher temperature was associated with a 90 per cent higher risk of esophageal cancer.

Скрыть анонс
13:28 Yahoo ScienceBayer shares plunge on new US cancer ruling

Shares in German chemicals and pharmaceuticals giant Bayer plunged as markets opened Wednesday, after a second US jury ruled that blockbuster pesticide Roundup -- made by recently-acquired Monsanto -- causes cancer. On Tuesday a California jury found that Monsanto's Roundup -- a herbicide built on active ingredient glyphosate -- caused cancer in a man who sprayed it on his garden over decades. It was the second such ruling within a year against Monsanto, with a first coming in August last year soon after Bayer sealed its $63-billion takeover of the firm.

Скрыть анонс
13:23 CNN HealthMonsanto's Roundup was likely the cause of a second man's cancer, jury says

In the first federal case of what could become thousands of lawsuits, a jury found the world's most widely used herbicide was likely responsible for a California man's cancer, according to the San Francisco Chronicle.

Скрыть анонс
12:04 Phys.orgBayer shares plunge on new US cancer ruling

Shares in German chemicals and pharmaceuticals giant Bayer plunged as markets opened Wednesday, after a second US jury ruled that blockbuster pesticide Roundup—made by recently-acquired Monsanto—causes cancer.

Скрыть анонс
10:43 News-Medical.NetDrinking hot tea associated with increased risk of esophageal cancer

Previous studies have revealed a link between hot tea drinking and risk of esophageal cancer, but until now, no study has examined this association using prospectively and objectively measured tea drinking temperature.

Скрыть анонс
10:43 BBC HealthWeedkiller glyphosate a 'substantial' cancer factor

Jury to consider damages after one of the world's most widely-used weedkillers is blamed for cancer.

Скрыть анонс
10:07 Phys.orgMonsanto's Roundup weedkiller contributed to US man's cancer: jury

The weedkiller Roundup was a "substantial factor" in the cancer of a US man who developed a lump in his throat after decades of spraying his garden—the second major legal defeat to agrochemical giant Monsanto in a year.

Скрыть анонс
09:26 News-Medical.NetNew analysis reveals precision oncology insights for colorectal cancer

Next-generation sequencing of tumor DNA from patients with colorectal cancer revealed genetic alterations that were linked to different survival and treatment outcomes in an analysis led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher.

Скрыть анонс
06:31 NYT HealthMonsanto Weed Killer Roundup Was ‘Substantial Factor’ in Causing Man’s Cancer, Jury Says

The finding was the first verdict from a federal jury in thousands of similar cases against the company.

Скрыть анонс
05:33 Yahoo ScienceSecond U.S. jury finds Bayer s Roundup caused cancer

Tuesday's unanimous jury decision in San Francisco federal court, which came after five days of deliberation, was not a finding of Bayer's liability for the cancer of plaintiff Edwin Hardeman. Bayer, which denies allegations that glyphosate or Roundup cause cancer, in a statement on Tuesday said it was disappointed with the jury's initial decision. Bayer acquired Monsanto, the longtime maker of Roundup, for $63 billion last year.

Скрыть анонс
05:33 Yahoo.com BusinessSecond U.S. jury finds Bayer s Roundup caused cancer

Tuesday's unanimous jury decision in San Francisco federal court, which came after five days of deliberation, was not a finding of Bayer's liability for the cancer of plaintiff Edwin Hardeman. Bayer, which denies allegations that glyphosate or Roundup cause cancer, in a statement on Tuesday said it was disappointed with the jury's initial decision. Bayer acquired Monsanto, the longtime maker of Roundup, for $63 billion last year.

Скрыть анонс
04:56 Yahoo ScienceRita Wilson on How Surviving Breast Cancer Shaped Her New Album

Actress and singer Rita Wilson explains the meaning behind her new album, ‘Halfway To Home’ and how some of the songs were influenced by her breast cancer journey.

Скрыть анонс
04:44 SeekingAlpha.comPfizer, Merck KGaA discontinue ovarian cancer drug trial

© seekingalpha.com. Use of this feed is limited to personal, non-commercial use and is governed by Seeking Alpha's Terms of Use (https://seekingalpha.com/page/terms-of-use). Publishing this feed for public or commercial use and/or misrepresentation by a third party is prohibited.

Скрыть анонс
03:17 Yahoo ScienceMatt Hancock: gene tests show I have a heightened risk of prostate cancer

Matt Hancock has revealed that he is at heightened risk of developing prostate cancer as he urges the NHS to roll out gene testing more widely. The Health Secretary said he has undergone tests which show that he has a higher rate of the disease than the average man, despite no family history of the cancer. Mr Hancock called for a national debate about the biggest ethical questions concerning a revolution in genomics, as he revealed that he was shocked by his own results. The tests found he has a 15 per cent chance of suffering prostate cancer by the age of 75 - a risk about 1.5 times greater than the average man. In a speech to The Royal Society, the Health Secretary will say the test may have saved his life, as he called for the urgent rollout of “predictive testing” across the NHS. Mr Hancock is expected to

Скрыть анонс
03:03 Reuters.com HealthSecond U.S. jury finds Bayer's Roundup caused cancer

A U.S. jury on Tuesday found Bayer AG's glyphosate-based Roundup weed killer caused cancer, a blow to the company eight months after another jury issued a $289 million verdict over similar claims in a different case.

Скрыть анонс
02:48 News-Medical.NetCompounds in coffee could slow prostate cancer growth

Researchers from Japan have noted that certain compounds in coffee could slow and even stop the progress of prostate cancer.

Скрыть анонс
02:27 Yahoo ScienceRoundup weed killer ‘substantial factor’ in causing man’s cancer, jury finds

A jury has found one of the world’s most widely-used weed killers to have been a “substantial factor” in causing a man’s cancer. The unanimous decision, made after five days of deliberations in San Francisco’s federal court, found that Roundup, Bayer AG’s weed killer, was responsible for California resident Edwin Hardeman’s non-Hodgkin lymphoma. It instead allows the trial to proceed to a second phase, which will determine the company’s potential liability and damages.

Скрыть анонс
02:27 Yahoo.com BusinessRoundup weed killer ‘substantial factor’ in causing man’s cancer, jury finds

A jury has found one of the world’s most widely-used weed killers to have been a “substantial factor” in causing a man’s cancer. The unanimous decision, made after five days of deliberations in San Francisco’s federal court, found that Roundup, Bayer AG’s weed killer, was responsible for California resident Edwin Hardeman’s non-Hodgkin lymphoma. It instead allows the trial to proceed to a second phase, which will determine the company’s potential liability and damages.

Скрыть анонс
02:15 Yahoo ScienceJury: Roundup weed killer is major factor in man's cancer

Roundup weed killer was a substantial factor in a California man's cancer, a jury determined Tuesday in the first phase of a trial that attorneys said could help determine the fate of hundreds of similar lawsuits. The unanimous verdict by the six-person jury in federal court in San Francisco came in a lawsuit filed against Roundup's manufacturer, agribusiness giant Monsanto. Edwin Hardeman, 70, was the second plaintiff to go to trial out of thousands around the country who claim the weed killer causes cancer.

Скрыть анонс
02:15 Yahoo.com BusinessJury: Roundup weed killer is major factor in man's cancer

Roundup weed killer was a substantial factor in a California man's cancer, a jury determined Tuesday in the first phase of a trial that attorneys said could help determine the fate of hundreds of similar lawsuits. The unanimous verdict by the six-person jury in federal court in San Francisco came in a lawsuit filed against Roundup's manufacturer, agribusiness giant Monsanto. Edwin Hardeman, 70, was the second plaintiff to go to trial out of thousands around the country who claim the weed killer causes cancer.

Скрыть анонс
01:39 BBC.comWeedkiller glyphosate a 'substantial' cancer factor

Jury to consider damages after one of the world's most widely-used weedkillers is blamed for cancer.

Скрыть анонс
01:27 Reuters.com HealthU.S. jury finds Bayer's Roundup caused man's cancer

A U.S. jury on Tuesday found Bayer AG's glyphosate-based weed killer caused a man's non-Hodgkin's lymphoma in a bellwether trial that may help determine the course of hundreds of similar cases.

Скрыть анонс
01:17 Yahoo ScienceMonsanto s Roundup weedkiller contributed to US man s cancer: jury

The weedkiller Roundup was a "substantial factor" in the cancer of a US man who developed a lump in his throat after decades of spraying his garden -- the second major legal defeat to agrochemical giant Monsanto in a year. Edwin Hardeman, 70, treated his property in Sonoma County, California, regularly with the herbicide from 1980 to 2012 and was eventually diagnosed with non-Hodgkin's lymphoma. "Now we can focus on the evidence that Monsanto has not taken a responsible, objective approach to the safety of Roundup," they added.

Скрыть анонс
01:06 SeekingAlpha.comJury finds Bayer’s Roundup weedkiller caused cancer; liability phase up next

© seekingalpha.com. Use of this feed is limited to personal, non-commercial use and is governed by Seeking Alpha's Terms of Use (https://seekingalpha.com/page/terms-of-use). Publishing this feed for public or commercial use and/or misrepresentation by a third party is prohibited.

Скрыть анонс
00:53 CNBC health careUS jury rules against Bayer in Roundup cancer case

A U.S. jury on Tuesday found Bayer AG's glyphosate-based weed killer to be a "substantial factor" in causing a man's non-Hodgkin's lymphoma, allowing the trial to proceed into a second phase on liability and damages.

Скрыть анонс
00:42 Reuters.com HealthU.S. jury rules against Bayer in Roundup cancer case

A U.S. jury on Tuesday found Bayer AG's glyphosate-based weed killer to be a "substantial factor" in causing a man's non-Hodgkin's lymphoma, allowing the trial to proceed into a second phase on liability and damages.

Скрыть анонс
00:33 Yahoo ScienceMonsanto: Roundup substantial factor in man’s cancer, jury finds in key verdict

Federal jury’s decision in case of man who said he used weedkiller for decades could affect hundreds of other plaintiffsThe decision in Edwin Hardeman’s case comes after a historic verdict last year that said Roundup caused another man’s terminal cancer. Photograph: Josh Edelson/AFP/Getty ImagesA federal jury in San Francisco found Monsanto’s Roundup herbicide was a substantial factor in causing the cancer of a California man, in a landmark verdict that could affect hundreds of other cases.Edwin Hardeman of Santa Rosa was the first person to challenge Monsanto’s Roundup in a federal trial and alleged that his exposure to Roundup caused him to develop non-Hodgkin’s lymphoma (NHL), a cancer that affects the immune system.In the next phase of the case, the jury will weigh liability and damages, and Hardeman’s lawyers

Скрыть анонс
00:33 Yahoo ScienceU.S. jury rules against Bayer in Roundup cancer case

The jury in San Francisco federal court in a unanimous ruling found Roundup, one of the world's most widely-used weed killers, to be responsible for the cancer of California resident Edwin Hardeman. The case will proceed into a second trial phase before the same jury on Wednesday to determine Bayer's liability and potential damages. Bayer did not immediately respond to a request for comment on Tuesday.

Скрыть анонс
00:33 Yahoo.com BusinessMonsanto: Roundup substantial factor in man’s cancer, jury finds in key verdict

Federal jury’s decision in case of man who said he used weedkiller for decades could affect hundreds of other plaintiffsThe decision in Edwin Hardeman’s case comes after a historic verdict last year that said Roundup caused another man’s terminal cancer. Photograph: Josh Edelson/AFP/Getty ImagesA federal jury in San Francisco found Monsanto’s Roundup herbicide was a substantial factor in causing the cancer of a California man, in a landmark verdict that could affect hundreds of other cases.Edwin Hardeman of Santa Rosa was the first person to challenge Monsanto’s Roundup in a federal trial and alleged that his exposure to Roundup caused him to develop non-Hodgkin’s lymphoma (NHL), a cancer that affects the immune system.In the next phase of the case, the jury will weigh liability and damages, and Hardeman’s lawyers

Скрыть анонс
00:33 Yahoo.com BusinessU.S. jury rules against Bayer in Roundup cancer case

The jury in San Francisco federal court in a unanimous ruling found Roundup, one of the world's most widely-used weed killers, to be responsible for the cancer of California resident Edwin Hardeman. The case will proceed into a second trial phase before the same jury on Wednesday to determine Bayer's liability and potential damages. Bayer did not immediately respond to a request for comment on Tuesday.

Скрыть анонс
00:33 CNBC.comUS jury rules against Bayer in Roundup cancer case

A U.S. jury on Tuesday found Bayer AG's glyphosate-based weed killer to be a "substantial factor" in causing a man's non-Hodgkin's lymphoma, allowing the trial to proceed into a second phase on liability and damages.

Скрыть анонс
19.03.2019
22:51 MedicalNewsToday.comMedical News Today: CBD for cancer: Everything you need to know

Cannabidiol, or CBD, is a compound in the cannabis plant. It may benefit people with cancer by reducing symptoms of the disease and its treatment. Learn more about the research here.

Скрыть анонс
22:20 Drugs.comTecentriq Approved for Small Cell Lung Cancer

TUESDAY, March 19, 2019 -- Tecentriq (atezolizumab) has been approved by the U.S. Food and Drug Administration to treat adults with extensive-stage small cell lung cancer (ES-SCLC). The drug has been approved as a first-line treatment for the...

Скрыть анонс
22:20 Drugs.comHormonal Therapy for Prostate Cancer Might Raise Depression Risk

TUESDAY, March 19, 2019 -- Hormonal treatment can help control prostate cancer but may increase a man's risk of depression, a new study by Danish researchers suggests. Male hormones, such as testosterone, are known to fuel the growth of prostate...

Скрыть анонс
21:34 Reuters.com HealthGSK reports positive data from trial of endometrial cancer drug

GlaxoSmithKline said on Tuesday a study testing its experimental drug dostarlimab in women with recurrent or advanced endometrial cancer showed promising results.

Скрыть анонс
21:24 SeekingAlpha.comGlaxo PD-1 inhibitor shows positive effect in endometrial cancer

Скрыть анонс
21:24 Yahoo ScienceGSK reports positive data from trial of endometrial cancer drug

GlaxoSmithKline said on Tuesday a study testing its experimental drug dostarlimab in women with recurrent or advanced endometrial cancer showed promising results. Results from the GARNET study showed the drug elicited clinically meaningful and durable response rates when used to treat certain types of tumors, GSK said. GSK said it would apply for marketing approval for dostarlimab in endometrial cancer at the end of 2019.

Скрыть анонс
21:24 Yahoo.com BusinessGSK reports positive data from trial of endometrial cancer drug

GlaxoSmithKline said on Tuesday a study testing its experimental drug dostarlimab in women with recurrent or advanced endometrial cancer showed promising results. Results from the GARNET study showed the drug elicited clinically meaningful and durable response rates when used to treat certain types of tumors, GSK said. GSK said it would apply for marketing approval for dostarlimab in endometrial cancer at the end of 2019.

Скрыть анонс
20:58 News-Medical.NetCholesterol lowering drug can also help treat cancer-associated cachexia

Brazilian researchers have discovered that a drug regularly prescribed to control cholesterol can also be used to treat cachexia, or wasting syndrome, a condition characterized by rapid weight loss and muscle atrophy associated with extreme physical weakness.

Скрыть анонс
20:58 MedicalNewsToday.comMedical News Today: How destroying a tumor promoter could lead to new cancer treatments

Mutated p53 tumor suppressor protein is a key driver of most cancers. Now, scientists have identified its mechanism of stability and how to disrupt it.

Скрыть анонс
20:02 News-Medical.NetNew class of drugs could help treat patients diagnosed with ovarian cancer

A team of researchers across The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.

Скрыть анонс
19:55 Yahoo ScienceRoche s Tecentriq Gets FDA Approval for Difficult Lung Cancer

Roche (RHHBY) gets an FDA approval of sBLA for Tecentriq in combination with chemotherapy for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC).

Скрыть анонс
19:44 Yahoo.com BusinessRoche s Tecentriq Gets FDA Approval for Difficult Lung Cancer

Roche (RHHBY) gets an FDA approval of sBLA for Tecentriq in combination with chemotherapy for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC).

Скрыть анонс
19:44 Yahoo.com BusinessSwamp cancer: Chincoteague ponies to get vaccine starting in April

Veterinarians plan to start the multi-step vaccination process in April. The vaccine will treat the fungus-like disease that leaves lesions on ponies.

Скрыть анонс
19:37 ScienceDaily.comAndrogen receptor, treatment target for prostate cancer, imports into mitochondria

Androgens stimulate prostate cancer cells to grow. Many drugs to target that cancer focus on stopping androgen biosynthesis or blocking the androgen receptor, or AR. Researchers have discovered a new function of the AR in prostate cells -- the AR is imported into and localizes to mitochondria of the cell, where it plays a novel role in regulating multiple mitochondrial processes.

Скрыть анонс
17:14 CancerNetwork.comSGO 2019: Pembrolizumab Combo Shows Clinical Benefit for Recurrent Epithelial Ovarian Cancer

Results of a phase II trial evaluating pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide were presented at SGO 2019.

Скрыть анонс
17:10 Medscape.ComCancer Drugs Dominate Top 10 Best-Selling Drugs in 2018

But Humira is the top seller in US 2 years running, while two immune checkpoint inhibitors break into the top 10.

Скрыть анонс
16:35 News-Medical.NetUCD researchers lead development of new urine test to detect prostate cancer

Cancer researchers at University College Dublin have led the development of a new test which uses urine to detect prostate cancer. Studies have so far shown the test to be 70% more specific for prostate cancer compared to the blood test currently used by doctors.

Скрыть анонс
16:27 Yahoo.com BusinessFDA puts partial hold on clinical trials of AbbVie s cancer drug

AbbVie Inc said on Tuesday the U.S. Food and Drug Administration placed a partial clinical hold on all trials of its cancer treatment Venclexta for multiple myeloma. The clinical hold does not impact any of the approved indications for Venclexta, such as chronic lymphocytic leukemia (CLL) or acute myeloid leukemia (AML), and is limited to investigational clinical trials in multiple myeloma, AbbVie said.

Скрыть анонс
16:25 Reuters.com HealthFDA puts partial hold on clinical trials of AbbVie's cancer drug

AbbVie Inc said on Tuesday the U.S. Food and Drug Administration placed a partial clinical hold on all trials of its cancer treatment Venclexta for multiple myeloma.

Скрыть анонс
16:16 Yahoo ScienceFDA puts partial hold on clinical trials of AbbVie s cancer drug

AbbVie Inc said on Tuesday the U.S. Food and Drug Administration placed a partial clinical hold on all trials of its cancer treatment Venclexta for multiple myeloma. The clinical hold does not impact any of the approved indications for Venclexta, such as chronic lymphocytic leukemia (CLL) or acute myeloid leukemia (AML), and is limited to investigational clinical trials in multiple myeloma, AbbVie said.

Скрыть анонс
16:15 CancerNetwork.comLymphadenectomy in Advanced Ovarian Cancer: Will It Improve Survival?

A randomized trial tested whether lymphadenectomy would improve survival outcomes in patients with advanced ovarian cancer.

Скрыть анонс
13:19 CancerNetwork.comQuiz: Current Controversies Surrounding Lymphadenectomy in Prostate Cancer

In our March prostate cancer quiz, you'll get a chance to test your knowledge of current controversies surrounding the use lymphadenectomy in prostate cancer. Here's your first question:   1. Pelvic lymph node dissection (PLND) has been definitively shown to improve which of the following among patients with prostate cancer?

Скрыть анонс
13:06 Technology.orgColorectal Cancer Screening Might Need to Start Sooner Than You Thought

Thinking you could wait till your 50th birthday to worry about colorectal cancer? Maybe not. New guidelines from the

Скрыть анонс
10:24 Yahoo ScienceCancer deaths falling for half decade in EU: study

The death rate from cancer has been falling for half a decade in the EU, researchers said Tuesday, although the overall number is expected to rise to 1.4 million this year due to an expanding population. The chances of dying from cancer for men has dropped about six percent from 139 deaths per 100,000 males in 2014 to 131 this year, according to a paper in the Annals of Oncology medical journal. The study showed that lung cancer among women will this year claim more lives than breast cancer -- 96,800 against 92,800.

Скрыть анонс
10:24 Yahoo.com BusinessCancer deaths falling for half decade in EU: study

The death rate from cancer has been falling for half a decade in the EU, researchers said Tuesday, although the overall number is expected to rise to 1.4 million this year due to an expanding population. The chances of dying from cancer for men has dropped about six percent from 139 deaths per 100,000 males in 2014 to 131 this year, according to a paper in the Annals of Oncology medical journal. The study showed that lung cancer among women will this year claim more lives than breast cancer -- 96,800 against 92,800.

Скрыть анонс
First← Previous12345678910Previous →Last